Study of Preoperative Docetaxel or Cisplatin (CDDP) + Docetaxel for C-stage IB-II Non-Small Cell Lung Cancer (NSCLC)
Status:
Completed
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of the preoperative
docetaxel and docetaxel-cisplatin combination in c-stage IB/II NSCLC, and select the optimal
preoperative therapy for phase III trials.